Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Regulators of angiogenesis and strategies for their therapeutic manipulation.

Milkiewicz M, Ispanovic E, Doyle JL, Haas TL.

Int J Biochem Cell Biol. 2006 Mar;38(3):333-57. Epub 2005 Nov 7. Review.

PMID:
16309946
[PubMed - indexed for MEDLINE]
2.

Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.

Vizán P, Sánchez-Tena S, Alcarraz-Vizán G, Soler M, Messeguer R, Pujol MD, Lee WN, Cascante M.

Carcinogenesis. 2009 Jun;30(6):946-52. doi: 10.1093/carcin/bgp083. Epub 2009 Apr 15.

PMID:
19369582
[PubMed - indexed for MEDLINE]
Free Article
3.

Redox signaling in angiogenesis: role of NADPH oxidase.

Ushio-Fukai M.

Cardiovasc Res. 2006 Jul 15;71(2):226-35. Epub 2006 May 9. Review.

PMID:
16781692
[PubMed - indexed for MEDLINE]
Free Article
4.

Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.

Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH, Dietmaier W, Bolder U, Schlitt HJ, Geissler EK, Stoeltzing O.

Mol Cancer Ther. 2007 Mar;6(3):1123-32.

PMID:
17363505
[PubMed - indexed for MEDLINE]
Free Article
5.

Anti-angiogenic function of tocotrienol.

Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T.

Asia Pac J Clin Nutr. 2008;17 Suppl 1:253-6.

PMID:
18296349
[PubMed - indexed for MEDLINE]
Free Article
6.

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

Byrne AM, Bouchier-Hayes DJ, Harmey JH.

J Cell Mol Med. 2005 Oct-Dec;9(4):777-94. Review.

PMID:
16364190
[PubMed - indexed for MEDLINE]
7.

Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.

Forooghian F, Das B.

Am J Ophthalmol. 2007 Nov;144(5):761-8. Epub 2007 Sep 17.

PMID:
17869204
[PubMed - indexed for MEDLINE]
8.

Role of nitric oxide in the modulation of angiogenesis.

Morbidelli L, Donnini S, Ziche M.

Curr Pharm Des. 2003;9(7):521-30. Review.

PMID:
12570800
[PubMed - indexed for MEDLINE]
9.

Angiogenesis--a new target for future therapy.

Pandya NM, Dhalla NS, Santani DD.

Vascul Pharmacol. 2006 May;44(5):265-74. Epub 2006 Mar 20. Review.

PMID:
16545987
[PubMed - indexed for MEDLINE]
10.

Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis.

Kuwabara M, Kakinuma Y, Ando M, Katare RG, Yamasaki F, Doi Y, Sato T.

J Physiol Sci. 2006 Feb;56(1):95-101.

PMID:
16779917
[PubMed - indexed for MEDLINE]
11.

Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis.

Perez-Pinera P, Berenson JR, Deuel TF.

Curr Opin Hematol. 2008 May;15(3):210-4. doi: 10.1097/MOH.0b013e3282fdc69e. Review.

PMID:
18391787
[PubMed - indexed for MEDLINE]
12.

Approaches for studying angiogenesis-related signal transduction.

Derakhshan B, Harrison KD, Miao QR, Sessa WC.

Methods Enzymol. 2008;443:1-23. doi: 10.1016/S0076-6879(08)02001-6.

PMID:
18772008
[PubMed - indexed for MEDLINE]
13.

IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.

Meyer RD, Sacks DB, Rahimi N.

PLoS One. 2008;3(12):e3848. doi: 10.1371/journal.pone.0003848. Epub 2008 Dec 3.

PMID:
19050761
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pathophysiological mechanisms of angiogenesis.

Walsh DA.

Adv Clin Chem. 2007;44:187-221. Review.

PMID:
17682343
[PubMed - indexed for MEDLINE]
15.

Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis.

Albig AR, Roy TG, Becenti DJ, Schiemann WP.

Angiogenesis. 2007;10(3):197-216. Epub 2007 Jul 14.

PMID:
17632767
[PubMed - indexed for MEDLINE]
16.

The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.

Zou GM, Karikari C, Kabe Y, Handa H, Anders RA, Maitra A.

J Cell Physiol. 2009 Apr;219(1):209-18. doi: 10.1002/jcp.21666.

PMID:
19097035
[PubMed - indexed for MEDLINE]
17.

Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.

Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G, Gessler M.

Exp Cell Res. 2007 Jan 1;313(1):1-9. Epub 2006 Sep 19.

PMID:
17045587
[PubMed - indexed for MEDLINE]
18.

Vascular endothelial growth factor (VEGF) inhibition--a critical review.

Moreira IS, Fernandes PA, Ramos MJ.

Anticancer Agents Med Chem. 2007 Mar;7(2):223-45. Review.

PMID:
17348829
[PubMed - indexed for MEDLINE]
19.

Redox signaling of angiogenesis.

Maulik N.

Antioxid Redox Signal. 2002 Oct;4(5):805-15. Review.

PMID:
12470509
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk